Total Debt Summary of Biogen Inc.

Biogen Inc.'s latest annual total debt in 2023 was 7.33 Billion USD , up 10.95% from previous year.
Biogen Inc.'s latest quarterly total debt in 2024 Q3 was 4.9 Billion USD , down -2.94% from previous quarter.
Biogen Inc. reported annual total debt of 6.61 Billion USD in 2022, down -13.01% from previous year.
Biogen Inc. reported annual total debt of 7.6 Billion USD in 2021, down -2.87% from previous year.
Biogen Inc. reported quarterly total debt of 6.94 Billion USD for 2024 Q1, down -5.34% from previous quarter.
Biogen Inc. reported quarterly total debt of 4.9 Billion USD for 2024 Q3, down -2.94% from previous quarter.

Annual Total Debt Chart of Biogen Inc. (2023 - 1989)

Historical Annual Total Debt of Biogen Inc. (2023 - 1989)

Year	Total Debt	Total Debt Growth
2023	7.33 Billion USD	10.95%
2022	6.61 Billion USD	-13.01%
2021	7.6 Billion USD	-2.87%
2020	7.82 Billion USD	22.94%
2019	6.36 Billion USD	7.26%
2018	5.93 Billion USD	0.03%
2017	5.93 Billion USD	-8.87%
2016	6.51 Billion USD	-0.13%
2015	6.52 Billion USD	1014.41%
2014	585.19 Million USD	-1.8%
2013	595.92 Million USD	-47.76%
2012	1.14 Billion USD	7.21%
2011	1.06 Billion USD	-11.59%
2010	1.2 Billion USD	9.42%
2009	1.09 Billion USD	-1.18%
2008	1.11 Billion USD	-28.78%
2007	1.56 Billion USD	1516.42%
2006	96.69 Million USD	122.57%
2005	43.44 Million USD	-94.89%
2004	850.3 Million USD	-4.17%
2003	887.27 Million USD	1997.66%
2002	42.29 Million USD	-48.52%
2001	82.16 Million USD	-24.85%
2000	109.32 Million USD	-3.31%
1999	113.06 Million USD	82.8%
1998	61.84 Million USD	-32.44%
1997	91.55 Million USD	38.15%
1996	66.27 Million USD	92.13%
1995	34.49 Million USD	0.0%
1994	- USD	0.0%
1993	- USD	0.0%
1992	- USD	0.0%
1991	- USD	0.0%
1990	- USD	0.0%
1989	- USD	-100.0%

Year	Total Debt	Total Debt Growth
2024 Q2	6.85 Billion USD	-1.35%
2024 Q1	6.94 Billion USD	-5.34%
2024 Q3	4.9 Billion USD	-2.94%
2023 Q3	7.71 Billion USD	17.09%
2023 Q2	6.58 Billion USD	-0.31%
2023 Q1	6.6 Billion USD	-0.07%
2023 FY	7.33 Billion USD	10.95%
2023 Q4	7.33 Billion USD	-4.89%
2022 Q2	7.55 Billion USD	-0.48%
2022 FY	6.61 Billion USD	-13.01%
2022 Q4	6.61 Billion USD	-0.3%
2022 Q3	6.63 Billion USD	-12.15%
2022 Q1	7.58 Billion USD	-0.21%
2021 FY	7.6 Billion USD	-2.87%
2021 Q2	7.63 Billion USD	-0.18%
2021 Q1	7.64 Billion USD	-2.31%
2021 Q4	7.6 Billion USD	-0.21%
2021 Q3	7.61 Billion USD	-0.18%
2020 Q3	7.83 Billion USD	-0.06%
2020 Q1	6.36 Billion USD	-0.03%
2020 FY	7.82 Billion USD	22.94%
2020 Q2	7.83 Billion USD	23.14%
2020 Q4	7.82 Billion USD	-0.08%
2019 Q4	6.36 Billion USD	0.05%
2019 Q1	6.37 Billion USD	7.46%
2019 Q2	6.37 Billion USD	-0.12%
2019 Q3	6.36 Billion USD	-0.12%
2019 FY	6.36 Billion USD	7.26%
2018 Q1	5.92 Billion USD	-0.09%
2018 Q4	5.93 Billion USD	0.09%
2018 Q3	5.93 Billion USD	0.05%
2018 FY	5.93 Billion USD	0.03%
2018 Q2	5.92 Billion USD	-0.02%
2017 Q3	5.93 Billion USD	-8.84%
2017 FY	5.93 Billion USD	-8.87%
2017 Q1	6.51 Billion USD	0.02%
2017 Q4	5.93 Billion USD	-0.06%
2017 Q2	6.51 Billion USD	-0.0%
2016 Q4	6.51 Billion USD	-0.26%
2016 Q1	6.54 Billion USD	0.29%
2016 Q2	6.54 Billion USD	0.04%
2016 Q3	6.52 Billion USD	-0.21%
2016 FY	6.51 Billion USD	-0.13%
2015 FY	6.52 Billion USD	1014.41%
2015 Q1	583.92 Million USD	-0.22%
2015 Q2	579.46 Million USD	-0.76%
2015 Q3	6.53 Billion USD	1027.66%
2015 Q4	6.52 Billion USD	-0.2%
2014 Q4	585.19 Million USD	-0.34%
2014 FY	585.19 Million USD	-1.8%
2014 Q3	587.19 Million USD	-0.39%
2014 Q2	589.47 Million USD	-0.86%
2014 Q1	594.56 Million USD	-0.23%
2013 Q2	729.57 Million USD	-20.28%
2013 Q1	915.14 Million USD	-19.78%
2013 FY	595.92 Million USD	-47.76%
2013 Q4	595.92 Million USD	-14.66%
2013 Q3	698.27 Million USD	-4.29%
2012 Q4	1.14 Billion USD	2.62%
2012 FY	1.14 Billion USD	7.21%
2012 Q2	1.09 Billion USD	1.41%
2012 Q3	1.11 Billion USD	1.56%
2012 Q1	1.07 Billion USD	1.44%
2011 FY	1.06 Billion USD	-11.59%
2011 Q3	1.06 Billion USD	-10.95%
2011 Q4	1.06 Billion USD	0.0%
2011 Q2	1.19 Billion USD	-0.45%
2011 Q1	1.2 Billion USD	-0.26%
2010 Q1	1.09 Billion USD	-0.42%
2010 FY	1.2 Billion USD	9.42%
2010 Q3	1.08 Billion USD	0.02%
2010 Q4	1.2 Billion USD	11.43%
2010 Q2	1.07 Billion USD	-1.41%
2009 FY	1.09 Billion USD	-1.18%
2009 Q4	1.09 Billion USD	-0.12%
2009 Q3	1.1 Billion USD	0.09%
2009 Q2	1.1 Billion USD	-0.82%
2009 Q1	1.1 Billion USD	-0.33%
2008 Q4	1.11 Billion USD	5.74%
2008 FY	1.11 Billion USD	-28.78%
2008 Q3	1.05 Billion USD	0.29%
2008 Q2	1.04 Billion USD	-2.2%
2008 Q1	1.07 Billion USD	-31.33%
2007 Q4	1.56 Billion USD	0.18%
2007 FY	1.56 Billion USD	1516.42%
2007 Q1	61.19 Million USD	-36.72%
2007 Q2	63.24 Million USD	3.36%
2007 Q3	1.56 Billion USD	2366.96%
2006 Q3	45.07 Million USD	1.23%
2006 Q4	96.69 Million USD	114.52%
2006 Q1	43.97 Million USD	1.23%
2006 FY	96.69 Million USD	122.57%
2006 Q2	44.52 Million USD	1.25%
2005 Q2	42.4 Million USD	-94.99%
2005 Q4	43.44 Million USD	1.21%
2005 Q1	846.43 Million USD	-0.46%
2005 FY	43.44 Million USD	-94.89%
2005 Q3	42.92 Million USD	1.23%
2004 Q3	845.7 Million USD	-2.37%
2004 FY	850.3 Million USD	-4.17%
2004 Q1	861.29 Million USD	-2.93%
2004 Q2	866.22 Million USD	0.57%
2004 Q4	850.3 Million USD	0.54%
2003 FY	887.27 Million USD	1997.66%
2003 Q2	39.85 Million USD	-30.59%
2003 Q1	57.41 Million USD	35.74%
2003 Q3	39.04 Million USD	-2.02%
2003 Q4	887.27 Million USD	2172.2%
2002 FY	42.29 Million USD	-48.52%
2002 Q4	42.29 Million USD	-41.85%
2002 Q3	72.74 Million USD	-5.43%
2002 Q2	76.92 Million USD	-1.7%
2002 Q1	78.25 Million USD	-4.75%
2001 FY	82.16 Million USD	-24.85%
2001 Q4	82.16 Million USD	-19.49%
2001 Q3	102.05 Million USD	-0.98%
2001 Q2	103.05 Million USD	-0.84%
2001 Q1	103.92 Million USD	-4.93%
2000 FY	109.32 Million USD	-3.31%
2000 Q4	109.32 Million USD	103.53%
2000 Q3	53.71 Million USD	-1.48%
2000 Q2	54.51 Million USD	-2.92%
2000 Q1	56.15 Million USD	-50.33%
1999 Q1	61.1 Million USD	-1.21%
1999 FY	113.06 Million USD	82.8%
1999 Q4	113.06 Million USD	92.94%
1999 Q3	58.6 Million USD	-1.35%
1999 Q2	59.4 Million USD	-2.78%
1998 Q1	89.2 Million USD	-2.57%
1998 Q2	78.9 Million USD	-11.55%
1998 Q3	82.3 Million USD	4.31%
1998 Q4	61.84 Million USD	-24.85%
1998 FY	61.84 Million USD	-32.44%
1997 Q1	70.8 Million USD	6.83%
1997 FY	91.55 Million USD	38.15%
1997 Q2	69.2 Million USD	-2.26%
1997 Q3	68.4 Million USD	-1.16%
1997 Q4	91.55 Million USD	33.85%
1996 Q2	52.7 Million USD	26.68%
1996 FY	66.27 Million USD	92.13%
1996 Q1	41.6 Million USD	20.6%
1996 Q3	61.7 Million USD	17.08%
1996 Q4	66.27 Million USD	7.41%
1995 Q4	34.49 Million USD	11.99%
1995 Q3	30.8 Million USD	23.2%
1995 Q1	25 Million USD	0.0%
1995 FY	34.49 Million USD	0.0%
1995 Q2	25 Million USD	0.0%
1994 Q3	- USD	0.0%
1994 Q1	- USD	0.0%
1994 Q2	- USD	0.0%
1994 Q4	- USD	0.0%
1994 FY	- USD	0.0%
1993 Q3	- USD	0.0%
1993 Q2	- USD	0.0%
1993 Q1	- USD	0.0%
1993 FY	- USD	0.0%
1993 Q4	- USD	0.0%
1992 Q3	- USD	0.0%
1992 Q1	- USD	0.0%
1992 Q4	- USD	0.0%
1992 FY	- USD	0.0%
1992 Q2	- USD	0.0%
1991 Q3	- USD	0.0%
1991 Q4	- USD	0.0%
1991 FY	- USD	0.0%
1991 Q1	- USD	0.0%
1991 Q2	- USD	0.0%
1990 FY	- USD	0.0%
1990 Q3	- USD	0.0%
1990 Q4	- USD	0.0%
1990 Q2	- USD	0.0%
1990 Q1	- USD	0.0%
1989 FY	- USD	-100.0%
1989 Q4	- USD	0.0%
1989 Q3	- USD	0.0%

Peer Total Debt Comparison of Biogen Inc.

Name	Total Debt	Total Debt Difference
Amgen Inc.	64.61 Billion USD	88.643%
AstraZeneca PLC	28.62 Billion USD	74.362%
Gilead Sciences, Inc.	24.98 Billion USD	70.632%
MIRA Pharmaceuticals, Inc.	5061.00 USD	-144994960.265%
Scilex Holding Company	128.46 Million USD	-5612.306%
Scilex Holding Company	128.46 Million USD	-5612.306%

Global Stocks Search

Biogen Inc. (BIIB)

Total Debt Summary of Biogen Inc.

Annual Total Debt Chart of Biogen Inc. (2023 - 1989)

Historical Annual Total Debt of Biogen Inc. (2023 - 1989)

Peer Total Debt Comparison of Biogen Inc.